Volpara Health Technologies Limited
VPAHF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $18 | $17 | $15 | $13 |
| % Growth | 10.1% | 9.3% | 17.1% | – |
| Cost of Goods Sold | $4 | $4 | $4 | $3 |
| Gross Profit | $14 | $13 | $12 | $10 |
| % Margin | 76.8% | 77.3% | 76.2% | 73.6% |
| R&D Expenses | $8 | $7 | $9 | $9 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $11 | $10 | $10 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $18 | $18 | $17 |
| Operating Income | -$5 | -$5 | -$7 | -$7 |
| % Margin | -24.7% | -29.6% | -45.1% | -54.3% |
| Other Income/Exp. Net | -$0 | -$0 | $2 | $0 |
| Pre-Tax Income | -$5 | -$5 | -$5 | -$7 |
| Tax Expense | -$1 | -$1 | -$0 | $1 |
| Net Income | -$4 | -$4 | -$5 | -$7 |
| % Margin | -22.2% | -24.9% | -31.3% | -57.5% |
| EPS | -0.016 | -0.016 | -0.019 | -0.03 |
| % Growth | 2.4% | 13.2% | 36.6% | – |
| EPS Diluted | -0.016 | -0.016 | -0.019 | -0.03 |
| Weighted Avg Shares Out | 254 | 252 | 252 | 252 |
| Weighted Avg Shares Out Dil | 254 | 252 | 252 | 252 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $3 | $3 | $2 | $2 |
| EBITDA | -$2 | -$3 | -$2 | -$4 |
| % Margin | -10% | -15.6% | -16% | -34.2% |